Compositions and methods for immunotherapy

The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes f...

Full description

Saved in:
Bibliographic Details
Main Authors Jones, Timothy David, McCreedy, Bruce, Carr, Francis Joseph
Format Patent
LanguageEnglish
Published 01.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
Bibliography:Application Number: US202016821535